
Early Stage Partners
Description
Early Stage Partners is a Cleveland, Ohio-based venture capital firm established in 2000, dedicated to providing early-stage financing to entrepreneurial companies primarily within the Midwest region. The firm positions itself as a crucial capital provider for nascent businesses, aiming to foster innovation and growth in its local ecosystem and beyond. Its strategic location in Cleveland allows it to tap into the burgeoning tech and life science sectors emerging from the region's strong academic and research institutions.
The firm's investment thesis centers on identifying high-potential startups across several key sectors, including technology, life sciences, advanced materials, and cleantech. Early Stage Partners is particularly interested in companies that demonstrate strong intellectual property, scalable business models, and experienced management teams. While its primary geographic focus is the Midwest, especially Ohio, the firm evaluates opportunities that align with its sector expertise and potential for significant returns, contributing to the development of a robust regional innovation economy.
Early Stage Partners has a history of deploying capital through multiple funds. Its second fund, Early Stage Partners II, closed in 2006 with commitments totaling $30 million, building upon the success of its initial $20 million fund. This capital is typically deployed in initial investments ranging from $250,000 to $1 million, providing essential seed and Series A funding to promising ventures. The firm also demonstrates a commitment to its portfolio companies through follow-on investments, potentially investing up to $3 million over the life of a company as it achieves key milestones and scales its operations. This patient capital approach underscores their long-term partnership strategy with founders.
Investor Profile
Early Stage Partners has backed more than 38 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 13% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Software, Medical Device.
- Typical check size: $250K – $1M.
Stage Focus
- Series B (34%)
- Series A (32%)
- Series C (18%)
- Series Unknown (8%)
- Series D (8%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Software
- Medical Device
- Biotechnology
- Saas
- Medical
- Electronics
- Enterprise Software
- Information Technology
- Manufacturing
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.